Skip to content

Clinical trials

Completed Lung Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Country / region: United Kingdom Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20083
20094
20102
20114
20124
20131
20142
20152
20165
20174
20182
20193
20201
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca12
Royal Brompton & Harefield NHS Foundation Trust4
Bayer2
Imperial College London2
Nottingham University Hospitals NHS Trust2
Vertex Pharmaceuticals Incorporated2
AlgiPharma AS1
Altesa Biosciences, Inc.1
British Thoracic Society1
Consorcio Centro de Investigación Biomédica en Red (CIBER)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases46
Respiratory Tract Diseases24
Pulmonary Disease, Chronic Obstructive13
Lung Diseases, Obstructive11
Asthma10
Bronchial Diseases7
Cystic Fibrosis7
Bronchitis, Chronic5
Digestive System Diseases5
Pancreatic Diseases5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.